These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25425621)

  • 1. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome.
    Kurano M; Suzuki A; Inoue A; Tokuhara Y; Kano K; Matsumoto H; Igarashi K; Ohkawa R; Nakamura K; Dohi T; Miyauchi K; Daida H; Tsukamoto K; Ikeda H; Aoki J; Yatomi Y
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):463-70. PubMed ID: 25425621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome.
    Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Kishimoto T; Miyazaki T; Nishino A; Nakajima N; Yaginuma K; Tamura H; Kojima T; Yokoyama K; Kurata T; Shimada K; Yatomi Y; Daida H
    Clin Chim Acta; 2012 Jan; 413(1-2):207-12. PubMed ID: 21983165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.
    Kurano M; Kano K; Dohi T; Matsumoto H; Igarashi K; Nishikawa M; Ohkawa R; Ikeda H; Miyauchi K; Daida H; Aoki J; Yatomi Y
    J Lipid Res; 2017 Feb; 58(2):433-442. PubMed ID: 28007846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome.
    Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Kurano M; Kishimoto T; Yanagisawa N; Ogita M; Miyazaki T; Nishino A; Yaginuma K; Tamura H; Kojima T; Yokoyama K; Kurata T; Shimada K; Daida H; Yatomi Y
    Atherosclerosis; 2013 Jul; 229(1):192-7. PubMed ID: 23664202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Laboratory Medicine of Lipid Mediators].
    Yatomi Y
    Rinsho Byori; 2015 Oct; 63(10):1183-6. PubMed ID: 26897854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood.
    Sano T; Baker D; Virag T; Wada A; Yatomi Y; Kobayashi T; Igarashi Y; Tigyi G
    J Biol Chem; 2002 Jun; 277(24):21197-206. PubMed ID: 11929870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids.
    Kurano M; Dohi T; Nojiri T; Kobayashi T; Hirowatari Y; Inoue A; Kano K; Matsumoto H; Igarashi K; Nishikawa M; Miyauchi K; Daida H; Ikeda H; Aoki J; Yatomi Y
    BBA Clin; 2015 Dec; 4():92-8. PubMed ID: 26675681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of plasma choline in acute coronary syndrome: importance of suitable sampling conditions for this assay.
    Ohkawa R; Kurano M; Sakai N; Kishimoto T; Nojiri T; Igarashi K; Hosogaya S; Ozaki Y; Dohi T; Miyauchi K; Daida H; Aoki J; Okubo S; Ikeda H; Tozuka M; Yatomi Y
    Sci Rep; 2018 Mar; 8(1):4725. PubMed ID: 29549312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y
    J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autotaxin-Lysophosphatidic Acid Pathway in Intraocular Pressure Regulation and Glaucoma Subtypes.
    Honjo M; Igarashi N; Kurano M; Yatomi Y; Igarashi K; Kano K; Aoki J; Weinreb RN; Aihara M
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):693-701. PubMed ID: 29392315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered plasma levels of lysophospholipids in response to adrenalectomy of rats.
    Tsutsumi T; Ino M; Shimizu Y; Kawabata K; Nishi H; Tokumura A
    Prostaglandins Other Lipid Mediat; 2021 Oct; 156():106579. PubMed ID: 34245896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis.
    Pamuklar Z; Federico L; Liu S; Umezu-Goto M; Dong A; Panchatcharam M; Fulkerson Z; Berdyshev E; Natarajan V; Fang X; van Meeteren LA; Moolenaar WH; Mills GB; Morris AJ; Smyth SS
    J Biol Chem; 2009 Mar; 284(11):7385-94. PubMed ID: 19139100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity.
    Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Tomiya T; Tejima K; Nishikawa T; Arai M; Yanase M; Aoki J; Arai H; Omata M; Fujiwara K; Yatomi Y
    Life Sci; 2007 Sep; 81(12):1009-15. PubMed ID: 17850827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
    Yatomi Y
    Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects.
    Ohkawa R; Kurano M; Mishima Y; Nojiri T; Tokuhara Y; Kishimoto T; Nakamura K; Okubo S; Hosogaya S; Ozaki Y; Yokota H; Igarashi K; Ikeda H; Tozuka M; Yatomi Y
    Clin Biochem; 2015 Jul; 48(10-11):690-7. PubMed ID: 25863111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diet and hyperlipidemia on levels and distribution of circulating lysophosphatidic acid.
    Kraemer MP; Mao G; Hammill C; Yan B; Li Y; Onono F; Smyth SS; Morris AJ
    J Lipid Res; 2019 Nov; 60(11):1818-1828. PubMed ID: 31484695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids.
    Nakamura K; Kishimoto T; Ohkawa R; Okubo S; Tozuka M; Yokota H; Ikeda H; Ohshima N; Mizuno K; Yatomi Y
    Anal Biochem; 2007 Aug; 367(1):20-7. PubMed ID: 17568554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lysophosphatidic acid is produced through diverse phospholipase pathways.
    Aoki J; Taira A; Takanezawa Y; Kishi Y; Hama K; Kishimoto T; Mizuno K; Saku K; Taguchi R; Arai H
    J Biol Chem; 2002 Dec; 277(50):48737-44. PubMed ID: 12354767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia.
    Omori W; Kano K; Hattori K; Kajitani N; Okada-Tsuchioka M; Boku S; Kunugi H; Aoki J; Takebayashi M
    Int J Neuropsychopharmacol; 2021 Dec; 24(12):948-955. PubMed ID: 34214158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity.
    Hosogaya S; Yatomi Y; Nakamura K; Ohkawa R; Okubo S; Yokota H; Ohta M; Yamazaki H; Koike T; Ozaki Y
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):364-8. PubMed ID: 18583620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.